IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-α and DTIC
IL-2-mediated augmentation of NK-cell activity and activation antigen expression on NK- and T-cell subsets in patients with metastatic melanoma treated with interferon-α and DTIC
复制标题
在接受干扰素-α 和 DTIC 治疗的转移性黑色素瘤患者中,IL-2 介导的 NK 细胞活性增强以及 NK 和 T 细胞亚群上的激活抗原表达增强
DOI:
10.1023/a:1027387930868
复制
发表时间:
2004
影响因子:
4
通讯作者:
I. Spuẑić
中科院分区:
文献类型:
--
作者:
G. Konjević;V. Jović;V. Jurišić;S. Radulović;S. Jelić;I. Spuẑić
Considering that well-defined and comprehensive immunological monitoring is the basis for the evaluation of the obtained immunmodulatory effects, we evaluated NK-cell activity, the number of CD3+CD4+, CD3+CD8+ T cells and CD16+CD56+ NK cells, as well as the expression of activation antigens, CD69, CD38 and HLA-DR on CD56+ NK cells, CD8+ and CD3+ T cells, simultaneously with IL-2 and TNF-α production, during chemoimmunotherapy with dacarbazine (DTIC) and interferon-α (IFN-α) in 39 patients with metastatic melanoma. In the first cycle of therapy, there was a significant rise in NK-cell activity, CD4+ T helper cell number, CD4/CD8 T-cell ratio, and the expression of activation antigens CD69 and CD38, on NK and T cells, respectively. However, in the following cycles there was a significant increase only in activation antigens without an increase in the percent or activity of NK cells. The early, but transient, immunopotentiation, present only in the first cycle of combined DTIC and IFN-α therapy, suggests that, in spite of increased IL-2 level, associated with augmented NK-cell activity, this therapy has a limited effect probably owing to the adverse effect of persistently high level of TNF-α in metastatic disease.
登录
查看更多内容
DOI:
--
发表时间:
1990
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Pantaleo,G;Koenig,S;Baseler,M;Lane,HC;Fauci,AS
通讯作者:
Fauci,AS
影响因子:
--
作者:
Biron,CA;Cousens,LP;Ruzek,MC;Su,HC;Salazar-Mather,TP
通讯作者:
Salazar-Mather,TP
影响因子:
11.2
作者:
SibbittJr,WL;Bankhurst,AD;Jumonville,AJ;Saiki,JH;Saiers,JH;Doberneck,RC
通讯作者:
Doberneck,RC
影响因子:
20.3
作者:
Ross, ME;Caligiuri, MA
通讯作者:
Caligiuri, MA